Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TORONTO , May 7, 2013 /CNW/ - Transition Therapeutics Inc. (“Transition” or the “Company”) (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the three and nine month periods ended March 31, 2013 .
Help employers find you! Check out all the jobs and post your resume.
